How AIX might be ushering in a new AI control paradigm, with interesting agentic safety inplications
Unpacking how recent progress in scaling active inference is already demonstrating real improvements for distributed control ...
Boston Cell Standards, Inc. (BCS), a private company bringing modern Quality tools and practices to Clinical Immunohistochemistry (IHC) testing worldwide, announced today that its IHC Reference ...
UL CEO Jennifer Scanlon on why safety still matters in the AI era ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results